Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Spyker

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|February 8, 2023
The authors' reply to comment on "Population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations"Daniel A Spyker
Clinical Toxicology (Philadelphia, Pa.)|March 1, 2018
NADH-methemoglobin reductase activity: adult versus childLuke Yip, Daniel A Spyker
The American Journal of Psychiatry|February 1, 2017
Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000-2014J Craig Nelson, Daniel A Spyker
Journal of Clinical Pharmacology|November 17, 2009
Pharmacokinetics of loxapine following inhalation of a thermally generated aerosol in healthy volunteersDaniel A Spyker, Patrik Munzar, James V Cassella
Journal of Clinical Pharmacology|March 27, 2015
Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimensDaniel A Spyker, Robert A Riesenberg, James V Cassella
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2015
A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteersJames V Cassella, Daniel A Spyker, Paul P Yeung
International Journal of Clinical Pharmacology and Therapeutics|October 27, 2015
A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteersJames V Cassella, Daniel A Spyker, Paul P Yeung
Clinical Toxicology (Philadelphia, Pa.)|August 27, 2021
Making US poison centers a part of the solution to the COVID-19 pandemicDaniel A Spyker, Alvin C Bronstein, Julie A Weber
Clinical Toxicology (Philadelphia, Pa.)|January 29, 2016
Relating calls to US poison centers for potential exposures to medications to Centers for Disease Control and Prevention reporting of influenza-like illnessGillian A Beauchamp, Nathanael J McKeown, Sergio Rodriguez, et al.
Pharmacology Research & Perspectives|March 30, 2016
Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction studyDaniel A Spyker, James V Cassella, Randall R Stoltz, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Clinical Toxicology (Philadelphia, Pa.)|February 8, 2023
The authors' reply to comment on "Population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations"Daniel A Spyker
Clinical Toxicology (Philadelphia, Pa.)|March 1, 2018
NADH-methemoglobin reductase activity: adult versus childLuke Yip, Daniel A Spyker
The American Journal of Psychiatry|February 1, 2017
Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000-2014J Craig Nelson, Daniel A Spyker
Journal of Clinical Pharmacology|November 17, 2009
Pharmacokinetics of loxapine following inhalation of a thermally generated aerosol in healthy volunteersDaniel A Spyker, Patrik Munzar, James V Cassella
Journal of Clinical Pharmacology|March 27, 2015
Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimensDaniel A Spyker, Robert A Riesenberg, James V Cassella
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2015
A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteersJames V Cassella, Daniel A Spyker, Paul P Yeung
International Journal of Clinical Pharmacology and Therapeutics|October 27, 2015
A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteersJames V Cassella, Daniel A Spyker, Paul P Yeung
Clinical Toxicology (Philadelphia, Pa.)|August 27, 2021
Making US poison centers a part of the solution to the COVID-19 pandemicDaniel A Spyker, Alvin C Bronstein, Julie A Weber
Clinical Toxicology (Philadelphia, Pa.)|January 29, 2016
Relating calls to US poison centers for potential exposures to medications to Centers for Disease Control and Prevention reporting of influenza-like illnessGillian A Beauchamp, Nathanael J McKeown, Sergio Rodriguez, et al.
Pharmacology Research & Perspectives|March 30, 2016
Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction studyDaniel A Spyker, James V Cassella, Randall R Stoltz, et al.
Pageof 5